Author(s): RodrguezAvial I, RodrguezAvial C, Lpez O, Culebras E, Picazo JJ
Abstract Share this page
Abstract During 2003 in our hospital, 236 clinical faecal Campylobacter spp. were isolated, of which 166 (70\%) were resistant to tetracycline and 199 (84\%) were resistant to ciprofloxacin by the disk diffusion method. Resistance to both antimicrobial agents was found in 146 isolates (62\%). The in vitro activity of tigecycline was compared with that of erythromycin, clindamycin and amoxicillin/clavulanic acid using the agar dilution method against 116 selected Campylobacter spp. that were resistant to both tetracycline and ciprofloxacin. The minimum inhibitory concentration at which 90\% of the isolates were inhibited (MIC90) was 0.06 mg/L for tigecycline and 4, 2 and 1 microg/mL for amoxicillin/clavulanic acid, erythromycin and clindamycin, respectively. The high in vitro activity of tigecycline against tetracycline- and ciprofloxacin-resistant strains suggests a potential therapeutic role in the treatment of infections that involve Campylobacter spp.
This article was published in Int J Antimicrob Agents
and referenced in Medicinal & Aromatic Plants